Pharmacist‐Led Hepatitis C Diagnosis and Rapid Management—In Community ( <scp>PHARM</scp> ‐C): Results From a Phase <scp>IV</scp> Nonblinded Randomised Controlled Trial
This was a nonblinded randomised controlled trial comparing pharmacist-led hepatitis C virus (HCV) treatment in the community, to tertiary care hepatology. Of 34 antibody-positive individuals, 28 completed a rapid HCV RNA test in the pharmacy. The study was terminated after randomising 11 participants over 15 months (recruitment continued until ~27 months), as a result of feasibility concerns of pharmacist-led care, and here we highlight important lessons learned to consider for future efforts.
Authors
- Camelia Capraru
- Da-Hee Chung
- Hemant Shah (ORCID: https://orcid.org/0000-0002-6423-2383)
- J Nicolle
- P. P. S. Gill (ORCID: https://orcid.org/0000-0001-7188-3689)
- Andrew Mendlowitz (ORCID: https://orcid.org/0000-0002-0178-5087)
- Bettina E. Hansen (ORCID: https://orcid.org/0000-0001-8307-3341)
- Mia J. Biondi (ORCID: https://orcid.org/0000-0002-1409-9908)
- Vincent Lam (ORCID: https://orcid.org/0000-0001-5566-4769)
- Guillaume Fontaine (ORCID: https://orcid.org/0000-0002-7806-814X)
- B. L. Harper
- Jordan J. Feld (ORCID: https://orcid.org/0000-0003-2640-2211)
- Anna Wilson (ORCID: https://orcid.org/0009-0001-5294-3911)
- Mediongo‐Abasi Usoro
- Cheryl Dale
- Bethany Barber
- David Morkos
- Matthew Boutrous
Institutions
- York University (CA)
- Walgreens (United States) (US)
- Health Solutions (Sweden) (SE)
- Maple Leaf Medical Clinic (CA)
- Toronto Liver Centre (CA)
- McGill University (CA)
Publication Details
- Journal
- Journal of Viral Hepatitis
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1111/jvh.70109
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- AbbVie Canada